Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22974871 | 0.92 | TMPRSS15 (1.00) | TMPRSS15 | |
| SCHEMBL22974887 | 0.87 | TMPRSS15 (1.00) | TMPRSS15 | |
| SCHEMBL22974882 | 0.87 | TMPRSS15 (1.00) | TMPRSS15 | |
| SCHEMBL22974832 | 0.84 | TMPRSS15 (1.00) | TMPRSS15 | |
| SCHEMBL22974833 | 0.81 | TMPRSS15 (1.00) | TMPRSS15PRSS1 | |
| SCHEMBL22974881 | 0.80 | TMPRSS15 (1.00) | TMPRSS15 | |
| SCHEMBL22974822 | 0.79 | TMPRSS15 (1.00) | TMPRSS15 | |
| SCHEMBL22974852 | 0.78 | TMPRSS15 (1.00) | TMPRSS15 | |
| SCHEMBL22974829 | 0.77 | TMPRSS15 (1.00) | TMPRSS15 | |
| SCHEMBL22974860 | 0.77 | TMPRSS15 (1.00) | TMPRSS15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3778577-B1 | NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITORY ACTIVITY | LG CHEMICAL LTD (KR) | 2023-08-30 | — | — | EP | claimed |
| US-11447480-B2 | Compound exhibiting enteropeptidase inhibitory activity | LG CHEM, LTD. (KR) | 2022-09-20 | — | — | US | claimed |
| US-20210284634-A1 | NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITORY ACTIVITY | LG CHEM, LTD. (KR) | 2021-09-16 | — | — | US | claimed |
| EP-3778577-A1 | NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITORY ACTIVITY | LG CHEM, LTD. (KR) | 2021-02-17 | — | — | EP | claimed |
| EP-3778577-B1 | NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITORY ACTIVITY | LG CHEMICAL LTD (KR) | 2023-08-30 | — | — | EP | disclosed |
| US-11447480-B2 | Compound exhibiting enteropeptidase inhibitory activity | LG CHEM, LTD. (KR) | 2022-09-20 | — | — | US | disclosed |
| US-11447480-B2 | Compound exhibiting enteropeptidase inhibitory activity | LG CHEM, LTD. (KR) | 2022-09-20 | — | — | US | disclosed |
| US-20210284634-A1 | NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITORY ACTIVITY | LG CHEM, LTD. (KR) | 2021-09-16 | — | — | US | disclosed |
| US-20210284634-A1 | NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITORY ACTIVITY | LG CHEM, LTD. (KR) | 2021-09-16 | — | — | US | disclosed |
| EP-3778577-A1 | NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITORY ACTIVITY | LG CHEM, LTD. (KR) | 2021-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210284634-A1 | NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITORY ACTIVITY | TMPRSS15, DPP9, LIPC | TMPRSS15 1/4885PRSS1 56/4885 |
| US-11447480-B2 | Compound exhibiting enteropeptidase inhibitory activity | TMPRSS15, DPP9, DPP4 | TMPRSS15 1/4885PRSS1 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.